FEATURED COMPANIES
- B. Braun Melsungen AG
- Cardinal Health, Inc.
- Danaher Corporation
- Hologic, Inc.
- Medtronic Plc.
- Olympus Corporation
The North America Smart Biopsy Market is expected to witness market growth of 4.53% CAGR during the forecast period (2019-2025).
Smart biopsy assists in the diagnosis of cancer and helps to distinguish between healthy cells and tumor cells. Interventional radiologists and the diagnostic department conduct the procedure to detect diseases for healthcare institutions such as diagnostic centers, medical clinics, and hospitals. About 100 types of cancers are categorized by their different organs, such as colon and rectum malignant melanoma, and more. Different types of biopsies are used for diagnosis, such as skin, shave, incision and excision, center needle, fine needle aspiration, and vacuum-assisted biopsies.
Recent years have witnessed a visible rise in cancer cases, which will consequently fuel the demand for minimally invasive biopsy procedures that will drive the overall smart biopsy market growth. Growing demand for minimally invasive biopsy can be seen as a major factor accelerating the overall growth of the market. This is due to the fact that minimally invasive procedures result in less scarring and rapid recovery. This aspect is expected to drive the adoption of breast cancer treatment and the diagnosis of skin cancer to avoid complications from conventional procedures.
Based on Application, the market is segmented into Breast cancer, Skin cancer, Liver cancer, Prostate cancer and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Danaher Corporation, Argon Medical Devices, Inc., Cardinal Health, Inc., Canon, Inc. (Canon Medical Systems Corporation), Boston Scientific Corporation, Olympus Corporation, Hologic, Inc., B. Braun Melsungen AG, Cook Medical, Inc. (Cook Group) and Medtronic Plc.
Scope of the Study
Market Segmentation:
By Application
By Country
Companies Profiled
Unique Offerings from the Publisher
Smart biopsy assists in the diagnosis of cancer and helps to distinguish between healthy cells and tumor cells. Interventional radiologists and the diagnostic department conduct the procedure to detect diseases for healthcare institutions such as diagnostic centers, medical clinics, and hospitals. About 100 types of cancers are categorized by their different organs, such as colon and rectum malignant melanoma, and more. Different types of biopsies are used for diagnosis, such as skin, shave, incision and excision, center needle, fine needle aspiration, and vacuum-assisted biopsies.
Recent years have witnessed a visible rise in cancer cases, which will consequently fuel the demand for minimally invasive biopsy procedures that will drive the overall smart biopsy market growth. Growing demand for minimally invasive biopsy can be seen as a major factor accelerating the overall growth of the market. This is due to the fact that minimally invasive procedures result in less scarring and rapid recovery. This aspect is expected to drive the adoption of breast cancer treatment and the diagnosis of skin cancer to avoid complications from conventional procedures.
Based on Application, the market is segmented into Breast cancer, Skin cancer, Liver cancer, Prostate cancer and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Danaher Corporation, Argon Medical Devices, Inc., Cardinal Health, Inc., Canon, Inc. (Canon Medical Systems Corporation), Boston Scientific Corporation, Olympus Corporation, Hologic, Inc., B. Braun Melsungen AG, Cook Medical, Inc. (Cook Group) and Medtronic Plc.
Scope of the Study
Market Segmentation:
By Application
- Breast cancer
- Skin cancer
- Liver cancer
- Prostate cancer and
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Companies Profiled
- Danaher Corporation
- Argon Medical Devices, Inc.
- Cardinal Health, Inc.
- Canon, Inc. (Canon Medical Systems Corporation)
- Boston Scientific Corporation
- Olympus Corporation
- Hologic, Inc.
- B. Braun Melsungen AG
- Cook Medical, Inc. (Cook Group)
- Medtronic Plc.
Unique Offerings from the Publisher
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- B. Braun Melsungen AG
- Cardinal Health, Inc.
- Danaher Corporation
- Hologic, Inc.
- Medtronic Plc.
- Olympus Corporation
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Market Analysis
Chapter 4. North America Smart Biopsy Market by Application
Chapter 5. North America Smart Biopsy Market by Country
Chapter 6. Company Profiles
Note: Product cover images may vary from those shown
- Danaher Corporation
- Argon Medical Devices, Inc.
- Cardinal Health, Inc.
- Canon, Inc. (Canon Medical Systems Corporation)
- Boston Scientific Corporation
- Olympus Corporation
- Hologic, Inc.
- B. Braun Melsungen AG
- Cook Medical, Inc. (Cook Group)
- Medtronic Plc.
Note: Product cover images may vary from those shown
LOADING...
